Mentions
Extended reach
Total likes
Video views
AI synopsis
The collection shows a strong consensus supporting the idea of a distinct obese HFpEF phenotype, with discussions emphasizing mechanistic details such as epicardial fat, pericardial restraint, and plasma volume expansion, using technical language indicative of deep engagement. The references to ongoing studies and clinical implications highlight the potential impact of this research on future treatment strategies.
Most discussions acknowledge the findings of the publication and support the idea of a distinct obese HFpEF phenotype, indicating a generally positive consensus.
The discussions reflect high interest, with users focusing on clinical implications, mechanisms, and ongoing research, demonstrating engagement with the topic.
Posts often refer to specific physiological mechanisms, clinical considerations, and ongoing studies, indicating a moderate level of deep engagement.
The discussions suggest that the research could influence future treatment approaches and understanding of HFpEF in obese patients, indicating a recognized potential for significant impact.
Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSHAM2021 Paper: https://t.co/7TwKESSimU #CardioEd https://t.co/VRcPHCWx3B
Answer: Obesity HFpEF phenotype with severe pericardial, epicardial fat over the RV causing pericardial constraint (not constrictive pericarditis--pericardium was normal). See: https://t.co/Sy7krJKTyg https://t.co/8rHupPG152
@Sandeepchennadi Here is the original paper, which describes it in detail: https://t.co/Sy7krJKTyg
@djc795 @naderjo @Steph_Achenbach @Obisht @mmamas1973 @mirvatalasnag @jedicath @SVRaoMD @aspergian1 @kaschenke @KardiologieHH @Hragy @rvprog @willsuh76 @lorenzbott @DavidLBrownMD @DFCapodanno The association with HF and HFpEF is particularly strong and probably causal although we need intervention studies of weight loss to prove causality for sure which are ongoing https://t.co/9ONlPRKo3w
@jeanlucvachiery @ATS_PC @awtpulmdoc @RyanTedfordMD 2/ High likelihood of high PAWP, either due to LV diast dysf or constrictive-like features promoted by excess epicardial and intrathoracic adipose tissue, along with plasma volume expansion. https://t.co/HF4O4Z1cnr
@iamritu @Charles_Kyr @AndreasGevaert @JGrapsa @rudolf_deboer @kevin_damman @GiuseppeGalati_ @AnastasiaSMihai @vass_vassiliou @hvanspall @DrWillWatson And we’ve observed this as well in part due to pseudo constriction physiology. https://t.co/9ONlPRKo3w
The 2022 AHA/ACC/HFSA Guideline for Heart Failure updates recommendations to improve patient-centered care. This video discusses the latest evidence-based practices and emphasizes aligning treatments with patient…
This video discusses the 2022 AHA/ACC/HFSA guidelines for heart failure management, emphasizing improvements in patient-centered care. It reviews evidence-based practices and new recommendations that align treatments…
RT @yreddyhf: @djc795 @naderjo @Steph_Achenbach @Obisht @mmamas1973 @mirvatalasnag @jedicath @SVRaoMD @aspergian1 @kaschenke @KardiologieHH…
@djc795 @naderjo @Steph_Achenbach @Obisht @mmamas1973 @mirvatalasnag @jedicath @SVRaoMD @aspergian1 @kaschenke @KardiologieHH @Hragy @rvprog @willsuh76 @lorenzbott @DavidLBrownMD @DFCapodanno The association with HF and HFpEF is particularly strong and probably causal although we need intervention studies of weight loss to prove causality for sure which are ongoing https://t.co/9ONlPRKo3w
RT @uni_pharmacist: MS13 HFpEFの診断と治療2022 小保方 優先生 「肥満HFpEF症例ではNP濃度が低い！」 NEPによるNP分解亢進も関与？ ARNI良いかも
RT @uni_pharmacist: MS13 HFpEFの診断と治療2022 小保方 優先生 「肥満HFpEF症例ではNP濃度が低い！」 NEPによるNP分解亢進も関与？ ARNI良いかも
Ref 1 / 3 https://t.co/q6ZSxNufD8
RT @sarahhudsonuk: Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSH…
RT @sarahhudsonuk: Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSH…
RT @sarahhudsonuk: Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSH…
RT @sarahhudsonuk: Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSH…
RT @sarahhudsonuk: Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSH…
Remember that in obese pts with HFpEF, there is a low NTproBNP despite a high PCWP Slide shared by @lamcardio at #BSHAM2021 Paper: https://t.co/7TwKESSimU #CardioEd https://t.co/VRcPHCWx3B
RT @CaravitaSergio: @jeanlucvachiery @ATS_PC @awtpulmdoc @RyanTedfordMD 2/ High likelihood of high PAWP, either due to LV diast dysf or con…
@jeanlucvachiery @ATS_PC @awtpulmdoc @RyanTedfordMD 2/ High likelihood of high PAWP, either due to LV diast dysf or constrictive-like features promoted by excess epicardial and intrathoracic adipose tissue, along with plasma volume expansion. https://t.co/HF4O4Z1cnr
@Sandeepchennadi Here is the original paper, which describes it in detail: https://t.co/Sy7krJKTyg
Answer: Obesity HFpEF phenotype with severe pericardial, epicardial fat over the RV causing pericardial constraint (not constrictive pericarditis--pericardium was normal). See: https://t.co/Sy7krJKTyg https://t.co/8rHupPG152
@iamritu @Charles_Kyr @AndreasGevaert @JGrapsa @rudolf_deboer @kevin_damman @GiuseppeGalati_ @AnastasiaSMihai @vass_vassiliou @hvanspall @DrWillWatson And we’ve observed this as well in part due to pseudo constriction physiology. https://t.co/9ONlPRKo3w
SH
SM
YR
SC
L
水心
と
TI
S
HR
JV
M
CB
AA